GSK3B and Insulin resistance: The activation of GSK3β in ECs after insulin resistance upregulates VCAM1 expression, and VCAM1’s ectodomain is cleaved by the metalloproteases ADAM10 and ADAM17, which also show increased expression in diabetic ECs.